Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase
Clinical trial NCT02032173 · TERMINATED
Trial details
- NCT number
- NCT02032173
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-19
- Primary completion
- 2015-04-29
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.